Clinical trial
Open-label Adjunctive Zonisamide for Bipolar Disorder
NCT00047567 · Elan Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00047567 |
|---|---|
| Title | Open-label Adjunctive Zonisamide for Bipolar Disorder |
| Lead sponsor | Elan Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorders |
| Intervention type | Drug |
| Interventions | zonisamide |
| Enrollment | 20 |
| Start date | Jul 1, 2002 |
| Completion | Jul 1, 2002 |
| First posted | Oct 10, 2002 |
| Last update posted | Dec 14, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: